Biolife Solutions (BLFS) Accumulated Expenses (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Accumulated Expenses data on file, last reported at $7.6 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $7.6 million, down 7.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 million (down 7.77% YoY), and the FY2025 annual result was $12.0 million, down 1.23% from the prior year.
• Accumulated Expenses declined to $7.6 million in Q1 2026 per BLFS's latest filing, from $12.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $12.1 million in Q4 2024 and troughed at $183000.0 in Q2 2024.
• A 5-year average of $8.2 million and a median of $8.9 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses plunged 98.19% in 2024, then jumped 5762.9% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $9.8 million in 2022, then declined by 6.76% to $9.1 million in 2023, then jumped by 32.91% to $12.1 million in 2024, then slipped by 1.23% to $12.0 million in 2025, then tumbled by 36.74% to $7.6 million in 2026.
• Business Quant data shows BLFS's Accumulated Expenses at $7.6 million in Q1 2026, $12.0 million in Q4 2025, and $10.9 million in Q3 2025.